Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
Few studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 pati...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/1/10 |
id |
doaj-3c15a93a78da40ccb0ed6a7493086145 |
---|---|
record_format |
Article |
spelling |
doaj-3c15a93a78da40ccb0ed6a74930861452020-11-25T02:06:56ZengMDPI AGDiagnostics2075-44182019-12-011011010.3390/diagnostics10010010diagnostics10010010Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral CarcinomaMakito Miyake0Nagaaki Marugami1Yuya Fujiwara2Kazumasa Komura3Teruo Inamoto4Haruhito Azuma5Hiroaki Matsumoto6Hideyasu Matsuyama7Kiyohide Fujimoto8Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanDepartment of Radiology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube 755-8505, JapanDepartment of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube 755-8505, JapanDepartment of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanFew studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 patients with cT1-3N0M0 ureteral carcinoma treated with NAC and radical nephroureterectomy. Hydronephrosis was classified into five grades based on computed tomography findings. We focused on the differences between the baseline and post-NAC status of ipsilateral hydronephrosis, radiographic tumor response, and blood markers. Down-grading, no change, and up-grading was observed in 10 (31%), 21 (66%), and 1 (3%) patients, respectively. In univariate analysis, locally advanced disease (cT3), severe hydronephrosis (grade 3/4) at baseline, no change/up-grading of hydronephrosis after NAC, and pathological lymphovascular involvement were identified as potential prognostic factors of progression-free and cancer-specific survival after radical nephroureterectomy. Locally advanced disease (cT3) at baseline and no change/up-grading of hydronephrosis by NAC were independently associated with poor progression-free survival. Notably, none of the patients with NAC-induced down-grading of hydronephrosis died of ureteral carcinoma during the follow-up. We reported the prognostic impact of down-grading of ipsilateral hydronephrosis, which could serve as a useful aid or clinical marker for decision-making.https://www.mdpi.com/2075-4418/10/1/10ureteral neoplasmshydronephrosisneoadjuvant therapyneoplasm recurrencesurvivaldisease progression |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Makito Miyake Nagaaki Marugami Yuya Fujiwara Kazumasa Komura Teruo Inamoto Haruhito Azuma Hiroaki Matsumoto Hideyasu Matsuyama Kiyohide Fujimoto |
spellingShingle |
Makito Miyake Nagaaki Marugami Yuya Fujiwara Kazumasa Komura Teruo Inamoto Haruhito Azuma Hiroaki Matsumoto Hideyasu Matsuyama Kiyohide Fujimoto Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma Diagnostics ureteral neoplasms hydronephrosis neoadjuvant therapy neoplasm recurrence survival disease progression |
author_facet |
Makito Miyake Nagaaki Marugami Yuya Fujiwara Kazumasa Komura Teruo Inamoto Haruhito Azuma Hiroaki Matsumoto Hideyasu Matsuyama Kiyohide Fujimoto |
author_sort |
Makito Miyake |
title |
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma |
title_short |
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma |
title_full |
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma |
title_fullStr |
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma |
title_full_unstemmed |
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma |
title_sort |
down-grading of ipsilateral hydronephrosis by neoadjuvant chemotherapy correlates with favorable oncological outcomes in patients undergoing radical nephroureterectomy for ureteral carcinoma |
publisher |
MDPI AG |
series |
Diagnostics |
issn |
2075-4418 |
publishDate |
2019-12-01 |
description |
Few studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 patients with cT1-3N0M0 ureteral carcinoma treated with NAC and radical nephroureterectomy. Hydronephrosis was classified into five grades based on computed tomography findings. We focused on the differences between the baseline and post-NAC status of ipsilateral hydronephrosis, radiographic tumor response, and blood markers. Down-grading, no change, and up-grading was observed in 10 (31%), 21 (66%), and 1 (3%) patients, respectively. In univariate analysis, locally advanced disease (cT3), severe hydronephrosis (grade 3/4) at baseline, no change/up-grading of hydronephrosis after NAC, and pathological lymphovascular involvement were identified as potential prognostic factors of progression-free and cancer-specific survival after radical nephroureterectomy. Locally advanced disease (cT3) at baseline and no change/up-grading of hydronephrosis by NAC were independently associated with poor progression-free survival. Notably, none of the patients with NAC-induced down-grading of hydronephrosis died of ureteral carcinoma during the follow-up. We reported the prognostic impact of down-grading of ipsilateral hydronephrosis, which could serve as a useful aid or clinical marker for decision-making. |
topic |
ureteral neoplasms hydronephrosis neoadjuvant therapy neoplasm recurrence survival disease progression |
url |
https://www.mdpi.com/2075-4418/10/1/10 |
work_keys_str_mv |
AT makitomiyake downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT nagaakimarugami downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT yuyafujiwara downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT kazumasakomura downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT teruoinamoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT haruhitoazuma downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT hiroakimatsumoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT hideyasumatsuyama downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma AT kiyohidefujimoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma |
_version_ |
1724931899840790528 |